Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Montelukast in Preventing Transaminase Elevation in Adult Dengue Patients: a Randomized, Double-blind, Placebo Controlled, Superiority Trial

NCT06747130 is registered in ClinicalTrials.gov with Phramongkutklao College of Medicine and Hospital as lead sponsor.

NCT NCT06747130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06747130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Montelukast in Preventing Transaminase Elevation in Adult Dengue Patients: a Randomized, Double-blind, Placebo Controlled, Superiority Trial
Lead sponsor
Phramongkutklao College of Medicine and Hospital
Phase
Phase 2/3
Overall status
Recruiting
Start date
January 31, 2025
Completion date
January 31, 2027
Enrollment
82 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dengue, montelukast, transaminases